HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Novel Use of Methylene Blue in the Pediatric ICU.

Abstract
Methylene blue (MB) is a medication commonly used to treat methemoglobinemia, reducing methemoglobin to hemoglobin. A novel use of MB, as detailed here, is in the treatment of refractory hypotension. A number of reports have detailed use of MB for this purpose in adults, but few data in pediatrics. A 22-month-old girl with Noonan syndrome, biventricular hypertrophic cardiomyopathy, and chronic positive pressure ventilation developed shock with tachycardia, hypotension, and fever after 3 days of diarrhea. She was critically ill, with warm extremities, bounding pulses, and brisk capillary refill. Laboratory tests revealed metabolic acidosis, low mixed venous oxygen saturation, and leukocytosis with bandemia. Treatment of severe septic shock was initiated with fluid resuscitation, inotropic support, sedation, and paralysis. She remained hypotensive despite norepinephrine at 0.7 μg/kg per minute, dopamine at 20 μg/kg per minute, and vasopressin at 0.04 U/kg per hour. Her vasoplegic shock worsened, despite aggressive conventional therapy. Intravenous MB was initiated, with a loading dose of 1 mg/kg followed by a continuous infusion at 0.25 mg/kg per hour. Upon initiation of MB, her systolic blood pressure increased by 33 points (40% increase), and diastolic blood pressure increased by 20 points (46% increase). She was able to wean off all inotropes quickly after initiation of MB. MB should be considered in the setting of refractory vasoplegic shock in the PICU.
AuthorsChrystal Rutledge, Brian Brown, Kimberley Benner, Priya Prabhakaran, Leslie Hayes
JournalPediatrics (Pediatrics) Vol. 136 Issue 4 Pg. e1030-4 (Oct 2015) ISSN: 1098-4275 [Electronic] United States
PMID26347436 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2015 by the American Academy of Pediatrics.
Chemical References
  • Enzyme Inhibitors
  • Methylene Blue
Topics
  • Combined Modality Therapy
  • Enzyme Inhibitors (therapeutic use)
  • Female
  • Humans
  • Hypotension (drug therapy, etiology)
  • Infant
  • Methylene Blue (therapeutic use)
  • Shock, Septic (complications, therapy)
  • Vasoplegia (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: